Related Experiment Video
Updated: Jan 30, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Proline metabolism reprogramming in cancer reveals the regulation of PRODH/POX as target
Yuxuan Zhou1, Ciqin Li2, Dingyuan Bai1
1Department of Pharmacy, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China; College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
Abstract:
Proline dehydrogenase (PRODH) plays a dual role in cancer by catalyzing the first step of proline catabolism. During tumor metabolic reprogramming, PRODH catalyzes the conversion of proline to Δ¹-pyrroline-5-carboxylate (P5C), which enters the tricarboxylic acid cycle and supports cancer cell growth and energy supply. However, the increased activity of PRODH also generates reactive oxygen species (ROS), which can induce apoptosis or autophagy, potentially inhibiting cancer progression or promoting cancer immune responses. This article analyzes the role of PRODH in various types of cancer and highlights its involvement in immune evasion. Additionally, this article discusses the potential of PRODH as a therapeutic target by providing a comprehensive analysis of current therapeutic strategies, including direct and indirect inhibitors. This framework provides a theoretical basis for precise metabolic therapy and combinatorial approaches to overcome therapeutic resistance.
More Related Videos
Related Concept Videos
Regulation of Metabolism
Targeted Cancer Therapies
There are several types of targeted therapies against...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
What is Metabolism?
Regulated mRNA Transport
Epigenetic Regulation

